Table 3.
Follow-Up Clinical and Treatment-Related Characteristics of Adult HIV Patients on ART at South Gondar Zone Public Hospitals, Ethiopia, September 11, 2017–September 10, 2022
| Variables | Outcome | Total | |
|---|---|---|---|
| Loss to Follow-Up | Censored | ||
| N (%) | N (%) | ||
| Opportunistic infection | |||
| Yes | 51 (9.31) | 170 (31.02) | 221 (40.33) |
| No | 62 (11.31) | 265 (48.36) | 327 (59.67) |
| TB screened | |||
| Yes | 101 (18.43) | 351 (64.05) | 452 (82.48) |
| No | 12 (2.19) | 84 (15.33) | 96 (17.52) |
| Current TB status | |||
| Positive | 7 (1.28) | 32 (5.84) | 39 (7.12) |
| Negative | 106 (19.34) | 403 (73.54) | 509 (92.88) |
| Drug regimen change | |||
| Yes | 58 (10.58) | 137 (25.00) | 195 (35.58) |
| No | 55 (10.04) | 298 (54.38) | 353 (64.42) |
| CPT therapy | |||
| Yes | 83 (15.15) | 272 (49.64) | 355 (64.78) |
| No | 30 (5.47) | 163 (29.74) | 193 (35.22) |
| INH prophylaxis therapy | |||
| Yes | 58 (10.58) | 148 (27.01) | 206 (37.59) |
| No | 55 (10.04) | 287 (52.37) | 342 (62.41) |
| Current hemoglobin level | |||
| <10 g/dL | 35 (6.39) | 155 (28.28) | 190 (34.67) |
| ≥10 g/dL | 78 (14.23) | 280 (51.09) | 358 (65.33) |
| Current viral load | |||
| ≤1000 copies/mL | 94 (17.15) | 333 (60.77) | 427 (77.92) |
| >1000 copies/mL | 19 (3.47) | 102 (18.61) | 121 (22.08) |
| ART adherence level | |||
| Good | 72 (13.14) | 230 (41.97) | 302 (55.11) |
| Fair | 35 (6.39) | 202 (36.86) | 237 (43.25) |
| Poor | 6 (1.09) | 3 (0.55) | 9 (1.64) |
| Substance use | |||
| Yes | 60 (10.95) | 128 (23.36) | 188 (34.31) |
| No | 53 (9.67) | 307 (56.02) | 360 (65.69) |